Abstract:Outbreaks of viral diseases are on the rise, fueling the search for antiviral therapeutics that act on a broad range of viruses while remaining safe to human host cells. In this research, we leverage the finding that the plasma membranes of host cells and the lipid bilayers surrounding enveloped viruses differ in lipid composition. We feature Piscidin 1 (P1), a cationic host defense peptide (HDP) that has antimicrobial effects and membrane activity associated with its N-terminal region where a cluster of aromatic residues and copper-binding motif reside. While few HDPs have demonstrated antiviral activity, P1 acts in the micromolar range against several enveloped viruses that vary in envelope lipid composition. Notably, it inhibits HIV-1, a virus that has an envelope enriched in cholesterol, a lipid associated with higher membrane order and stability. Here, we first document through plaque assays that P1 boasts strong activity against SARS-CoV-2, which has an envelope low in cholesterol. Second, we extend previous studies done with homogeneous bilayers and devise cholesterol-containing zwitterionic membranes that contain the liquid disordered (L d ; low in cholesterol) and ordered (L o , rich in cholesterol) phases. Using dye leakage assays and cryo-electron microscopy on vesicles, we show that P1 has dramatic permeabilizing capability on the L o /L d , an effect matched by a strong ability to aggregate, fuse, and thin the membranes. Differential scanning calorimetry and NMR experiments demonstrate that P1 mixes the lipid content of vesicles and alters the stability of the L o . Structural studies by NMR indicate that P1 interacts with the L o /L d by folding into an α-helix that lies parallel to the membrane surface. Altogether, these results show that P1 is more disruptive to phase-separated than homogenous cholesterol-containing bilayers, suggesting an ability to target domain boundaries. Overall, this multi-faceted research highlights how a peptide that interacts strongly with membranes through an aromatic-rich N-terminal motif disrupt viral envelope mimics. This represents an important step towards the development of novel peptides with broad-spectrum antiviral activity.

Antiviral Activity Of A Cloned Peptide Rc28 Isolated From The Higher Basidiomycetes Mushroom Rozites Caperata In A Mouse Model Of Hsv-1 Keratitis

Evaluation of a theta-defensin in a Murine model of herpes simplex virus type 1 keratitis

The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model

Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation

Evaluating the therapeutic efficacy of triptolide and (S)-10-hydroxycamptothecin on cutaneous and ocular Herpes Simplex Virus type-1 infections in mice

Targeted delivery of herpes simplex virus glycoprotein D to CD169+ macrophages using ganglioside liposomes alleviates herpes simplex keratitis in mice

Myricetin inhibits pseudorabies virus infection through direct inactivation and activating host antiviral defense

Antiviral activity of the host defense peptide piscidin 1: investigating a membrane-mediated mode of action

Inhibition of pathologic retinal neovascularization by a small peptide derived from human apolipoprotein(a).

Therapeutic Strategy for the Prevention of Pseudorabies Virus Infection in C57BL/6 Mice by 3D8 scFv with Intrinsic Nuclease Activity

Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice

An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.

The antiherpetic and anti-inflammatory activity of the frog-derived peptide Hylin-a1

Small Molecule RAF265 as an Antiviral Therapy Acts Against HSV‐1 by Regulating Cytoskeleton Rearrangement and Cellular Translation Machinery

A Supramolecular Gel with Unique Rheological Properties for Treating Corneal Virus Infection

Prophylactic Antiheparanase Activity by PG545 Is Antiviral In Vitro and Protects against Ross River Virus Disease in Mice

NSC23766 and Ehop016 Suppress Herpes Simplex Virus-1 Replication by Inhibiting Rac1 Activity.

Antiviral activity of temporin-1CEb analogues against gingival infection with herpes simplex virus type 1

Phosphorylcholine and KR12-Containing Corneal Implants in HSV-1-Infected Rabbit Corneas

R430: A potent inhibitor of DNA and RNA viruses

Modified host defence peptide GF19 slows TNT-mediated spread of corneal herpes simplex virus serotype I infection